CLOSE
WEBSITE OF THE STATE OF SOUTH DAKOTA DEPARTMENT OF HEALTH
Kim Malsam-Rysdon, Secretary of Health

South Dakota Department of Health Logo and covid.sd.gov button.

COVID-19 Vaccine Information

for healthcare providers

NOTE: Please check this web page twice weekly for updated material.

Provider Enrollment Instructions

Vaccinator TrainingStorage & Handling TrainingVaccine Data Entry Training Vaccine Coordinator Training

COVID-19 Vaccine Safety FAQs

CDC issues urgent health advisory to increase COVID-19 vaccination for people before, after, or during pregnancy

On September 29, 2021, CDC issued an urgent health advisory to increase COVID-19 vaccination among people who are pregnant, recently were pregnant (including those who are lactating), are trying to become pregnant, or might become pregnant in the future. A portion of the media statement appears below. 

The CDC health advisory strongly recommends COVID-19 vaccination either before or during pregnancy because the benefits of vaccination for both pregnant persons and their fetus or infant outweigh known or potential risks. Additionally, the advisory calls on health departments and clinicians to educate pregnant people on the benefits of vaccination and the safety of recommended vaccines.

According to CDC data, only 31 percent of pregnant people have been vaccinated against COVID-19 and vaccination rates vary markedly by race and ethnicity. Vaccination coverage is highest among Asian people who are pregnant (45.7 percent), but lower among Hispanic or Latino pregnant people (25 percent), and lowest among Black pregnant people (15.6 percent).

Through September 27th, there were more than 125,000 confirmed cases of COVID-19 in pregnant people including more than 22,000 hospitalized and 161 deaths; of which, 22 deaths occurred in the month of August alone. Cases of COVID-19 in symptomatic, pregnant people have a two-fold risk of admission into intensive care and a 70 percent increased risk of death. Pregnant people with COVID-19 are at increased risk of adverse pregnancy outcomes that could include preterm birth, stillbirth, and admission into the ICU of a newborn also infected with COVID-19.


September 24, 2021 - CDC’s independent Advisory Committee on Immunization Practices (ACIP) recommended certain populations receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least six months after the completion of their Pfizer vaccine primary series. In addition, the CDC Director recommended a booster dose for those in high risk occupational and institutional settings.

CDC recommends:

  • people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;

  • people aged 50 to 64 with certain underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;

  • people 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks; and 

  • people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.

CDC Update on COVID-19 Vaccination during Pregnancy: Key Messages and Talking Points for Partners (updated August 11, 2021)

COVID-19 Vaccine Effectiveness FAQs

Pfizer-BioNTech Resources:

Contact Information: https://www.pfizer.com/contact

COVID-19 Vaccine 3rd dose/booster shots FAQs COVID-19 Vaccine General FAQs COVID-19 Vaccine General FAQs

Resources:

Contact Information:

COVID-19 Vaccine General FAQs

VAERS Website - Healthcare providers are required by law to report to VAERS

Contact VAERS at:

  • Phone: 800-822-7967 | Fax: 877-721-0366 | E-mail: info@vaers.org   

  • For non-urgent concerns, email covid19vaxsafety@cdc.gov. For emergencies relating to COVID-19 vaccine safety, call CDC Emergency Operations Center at (770) 488-7100.

 
COVID-19 Vaccine General FAQs

v-safe website - CDC is requesting that healthcare providers give patients a v-safe information sheet at the time of vaccination and encourage them to enroll and fill out the surveys when prompted to do so.

Contact Information: Call 800-232-4636 | TTY 888-232-6348 | Open 24 hours, 7 days a week

COVID-19 Vaccine General FAQs

Vaccination Clinic Guidance

Long-Term Care Facility Guidance

Storage and Handling Guidance

Post-Vaccination Guidance

Fact Sheets & Communication Resources

South Dakota Vaccination Plan

Share via: